These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 30398985)
1. Syringocystadenoma Papilliferum of the Anogenital Area and Buttocks: A Report of 16 Cases, Including Human Papillomavirus Analysis and HRAS and BRAF V600 Mutation Studies. Konstantinova AM; Kyrpychova L; Nemcova J; Sedivcova M; Bisceglia M; Kutzner H; Zamecnik M; Sehnalkova E; Pavlovsky M; Zateckova K; Shvernik S; Spurkova Z; Michal M; Kerl K; Kazakov DV Am J Dermatopathol; 2019 Apr; 41(4):281-285. PubMed ID: 30398985 [TBL] [Abstract][Full Text] [Related]
2. Syringocystadenoma papilliferum associated with verrucous carcinoma of the skin in the same lesion: Report of four cases. Alegría-Landa V; Jo-Velasco M; Santonja C; Eraña I; Vergara-Sanchez A; Kutzner H; Requena L J Cutan Pathol; 2020 Jan; 47(1):12-16. PubMed ID: 31449665 [TBL] [Abstract][Full Text] [Related]
3. Contiguous verrucous proliferations in syringocystadenoma papilliferum: A retrospective analysis with additional evaluation via mutation-specific BRAFV600E immunohistochemistry. Friedman BJ; Sahu J; Solomides CC; Connolly DM; Lee JB J Cutan Pathol; 2018 Mar; 45(3):212-216. PubMed ID: 29206289 [TBL] [Abstract][Full Text] [Related]
4. [Cystic tubulopapillary adenoma with apocrine differentiation and BRAF V600E mutation. A case report and review of the literature]. Moreno Ontalba A; Gómez Durán Á; Ruiz Cabezas L; Cidoncha Pérez E; Díaz Delgado M; Rubio Fernández A Rev Esp Patol; 2022 Sep; 55 Suppl 1():S64-S68. PubMed ID: 36075666 [TBL] [Abstract][Full Text] [Related]
5. Activating mutations in the RAS/mitogen-activated protein kinase signaling pathway in sporadic trichoblastoma and syringocystadenoma papilliferum. Shen AS; Peterhof E; Kind P; Rütten A; Zelger B; Landthaler M; Berneburg M; Hafner C; Groesser L Hum Pathol; 2015 Feb; 46(2):272-6. PubMed ID: 25532942 [TBL] [Abstract][Full Text] [Related]
6. BRAF and KRAS mutations in tubular apocrine adenoma and papillary eccrine adenoma of the skin. Liau JY; Tsai JH; Huang WC; Lan J; Hong JB; Yuan CT Hum Pathol; 2018 Mar; 73():59-65. PubMed ID: 29241739 [TBL] [Abstract][Full Text] [Related]
7. Syringocystadenoma papilliferum on the mons pubis. Suzuki S; Al-Hajjaj S; Lee M; Bhawan J Dermatol Online J; 2018 Apr; 24(4):. PubMed ID: 29906013 [TBL] [Abstract][Full Text] [Related]
8. Grouped apocrine gland component associated with sporadic syringocystadenoma papilliferum: A case report and BRAFV600E mutation analysis of the two components. Mitsui Y; Ogawa K; Takeda M; Kuwahara M; Fukumoto T; Asada H J Dermatol; 2019 Nov; 46(11):e395-e398. PubMed ID: 31294472 [No Abstract] [Full Text] [Related]
10. Complex sweat gland hamartoma: A case report. Skopec Z; Berrebi KG; Stone M; Liu V J Cutan Pathol; 2023 Mar; 50(3):243-246. PubMed ID: 36323653 [TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic Study of Sialadenoma Papilliferum of the Minor Salivary Glands: A Series of 8 New Cases With BRAF V600E Mutation-specific Immunohistochemical Analysis. Owosho AA; Shasteen AM; Aguirre SE; Summersgill KF Int J Surg Pathol; 2023 Oct; 31(7):1265-1272. PubMed ID: 36632022 [No Abstract] [Full Text] [Related]
12. Syringocystadenoma papilliferum arising in a naevus sebaceous. Faheem NAA; Kwan Z; Yong ASW; Ch'ng CC; Tan KK; Naicker M; Tan LL Malays J Pathol; 2019 Apr; 41(1):47-49. PubMed ID: 31025637 [TBL] [Abstract][Full Text] [Related]
13. Tubulopapillary Cystic Adenoma With Apocrine Differentiation: A Unifying Concept for Syringocystadenoma Papilliferum, Apocrine Gland Cyst, and Tubular Papillary Adenoma. Ansai SI; Anan T; Fukumoto T; Saeki H Am J Dermatopathol; 2017 Nov; 39(11):829-837. PubMed ID: 28033156 [TBL] [Abstract][Full Text] [Related]
14. Condyloma acuminatum associated with syringocystadenoma papilliferum. Skelton HG; Smith KJ; Young D; Lupton GP Am J Dermatopathol; 1994 Dec; 16(6):628-30. PubMed ID: 7864300 [TBL] [Abstract][Full Text] [Related]
15. Dermoscopy of syringocystadenoma papilliferum. Lombardi M; Piana S; Longo C; Borsari S; Persechino F; Argenziano G; Moscarella E Australas J Dermatol; 2018 Feb; 59(1):e59-e61. PubMed ID: 28695704 [TBL] [Abstract][Full Text] [Related]
16. Syringocystadenoma papilliferum contiguous to a verrucous cyst. Li A; Sanusi ID; Pena JR; Nopajaroonsri C; Kent M; Smoller BR J Cutan Pathol; 2003 Jan; 30(1):32-6. PubMed ID: 12534802 [TBL] [Abstract][Full Text] [Related]
18. Contiguous squamous proliferations in syringocystadenoma papilliferum: A retrospective study of 14 cases. Aggarwal D; Chatterjee D; Keshavamurthy V; Chhikara K; Saikia UN; Radotra BD; De D; Singh MP Indian J Dermatol Venereol Leprol; 2023; 89(2):266-273. PubMed ID: 34623039 [TBL] [Abstract][Full Text] [Related]
19. [Anatomoclinical and immunohistochemical study of hidradenoma papilliferum, a tumor deriving from anogenital mammary-like glands]. Blind A; Weingertner N; Cribier B Ann Dermatol Venereol; 2019 Sep; 146(8-9):528-536. PubMed ID: 31285043 [TBL] [Abstract][Full Text] [Related]
20. Intradermal Syringocystadenoma Papilliferum on the Popliteal Fossa: A Rare Dermal Variant in an Atypical Location. Omer M; Na S; Joshipura D; Robinson-Bostom L R I Med J (2013); 2024 Jul; 107(7):14-16. PubMed ID: 38917308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]